No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs571020027 |
chr12:26109586-26109587 |
Weak transcription Enhancers Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs575154105 |
chr12:26109631-26109632 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs1149808 |
chr12:26109635-26109636 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs563828479 |
chr12:26109653-26109654 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs144089504 |
chr12:26109670-26109671 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs543496074 |
chr12:26109753-26109754 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs56738730 |
chr12:26109754-26109755 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs1149807 |
chr12:26109755-26109756 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs141494094 |
chr12:26109780-26109781 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs861218 |
chr12:26109785-26109786 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs865507 |
chr12:26109793-26109794 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs864917 |
chr12:26109799-26109800 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs75894153 |
chr12:26109872-26109873 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs1167547 |
chr12:26109902-26109903 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs113278083 |
chr12:26109903-26109904 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs546960243 |
chr12:26109923-26109924 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs142444264 |
chr12:26109946-26109947 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs186349012 |
chr12:26109974-26109975 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs147655573 |
chr12:26109975-26109976 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs189380989 |
chr12:26109981-26109982 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs181020475 |
chr12:26109993-26109994 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs140737066 |
chr12:26110017-26110018 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs552616012 |
chr12:26110041-26110042 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs553799875 |
chr12:26110052-26110053 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs111945881 |
chr12:26110057-26110058 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs371005340 |
chr12:26110058-26110059 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs565983002 |
chr12:26110101-26110102 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs144892165 |
chr12:26110109-26110110 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs186049860 |
chr12:26110114-26110115 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs575217085 |
chr12:26110130-26110131 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs534915873 |
chr12:26110132-26110133 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs117347081 |
chr12:26110146-26110147 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs191365575 |
chr12:26110181-26110182 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs28712704 |
chr12:26110197-26110198 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs575779570 |
chr12:26110216-26110217 |
Flanking Active TSS Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs543182221 |
chr12:26110293-26110294 |
Flanking Active TSS Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs146977652 |
chr12:26110342-26110343 |
Flanking Active TSS Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs565013828 |
chr12:26110372-26110373 |
Flanking Active TSS Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs74448691 |
chr12:26110388-26110389 |
Flanking Active TSS Enhancers Weak transcription Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs79717396 |
chr12:26110408-26110409 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs540628599 |
chr12:26110428-26110429 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs76951545 |
chr12:26110443-26110444 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs368765054 |
chr12:26110444-26110445 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs140630853 |
chr12:26110457-26110458 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs4963944 |
chr12:26110484-26110485 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs181095410 |
chr12:26110501-26110502 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs113219994 |
chr12:26110518-26110519 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG islandlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs185903838 |
chr12:26110547-26110548 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs552048701 |
chr12:26110565-26110566 |
Active TSS Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs12424238 |
chr12:26110610-26110611 |
Active TSS Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
mRNA abundance
|